Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outlook Therapeutics (OTLK) Tax Provisions (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed Tax Provisions for 7 consecutive years, with $2800.0 as the latest value for Q1 2025.

  • Quarterly Tax Provisions changed N/A to $2800.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$5.9 million through Sep 2025, changed N/A year-over-year, with the annual reading at $2800.0 for FY2025, 0.0% changed from the prior year.
  • Tax Provisions for Q1 2025 was $2800.0 at Outlook Therapeutics, up from -$3.3 million in the prior quarter.
  • The five-year high for Tax Provisions was $2800.0 in Q1 2025, with the low at $2800.0 in Q1 2025.